Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2004
05/18/2004US6737401 Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
05/18/2004US6737398 Administering tumor necrosis factor-alpha directly to lung tissue
05/18/2004US6737280 Used as labeling groups in procedures for the detection of analytes; asymmetric monobenzoxanthene compounds
05/18/2004US6737279 Tuning the properties of conjugated polyelectrolytes and application in a biosensor platform
05/18/2004US6737278 Flow matrix contains separation zones to retard or separate a component capable of disturbingor influencing the signal from the signal complex
05/18/2004US6737277 Comprising a base member, an array disposed on the base member, and assay indicia zone; increased sensitivity compared to previous migration type assays due to filter element before assay indiciazone
05/18/2004US6737276 Method and device for determining the total organic carbon content in liquids, especially ultra-pure water
05/18/2004US6737275 Obtaining serum; obtaining a reaction mixture of an acrylating compound and perchlorate ion; reacting to produce colored product; measuring spectral data for colored product; applying multiple wavelength detectiion with statistical analysis
05/18/2004US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
05/18/2004US6737263 Monitoring and controlling biocatalytic efficiency of wastewater treatment; obtain activated sludge, sample wastewater, measure concentration of interior storage particles, adjust feed nutrients
05/18/2004US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6
05/18/2004US6737245 Luciferase expression cassettes and methods of use
05/18/2004US6737244 Ubiquitin ligase assay
05/18/2004US6737243 Determination of the hydrophobic pulmonary surfactant protein SP-C
05/18/2004US6737242 Assaying compounds for cognitive enhancing properties, anxiolytic, hypnotic, or antidepressant properties; gamma aminobutyric acid (gaba)
05/18/2004US6737241 Methods for screening for transdominant intracellular effector peptides and RNA molecules
05/18/2004US6737240 Methods of screening for a multi-drug resistance conferring peptide
05/18/2004US6737238 Substrate measuring method and device
05/18/2004US6737233 Method for preparing HCV E2 binding protein
05/18/2004US6737232 IAPs associated cell cycle proteins, compositions and methods of use
05/18/2004US6737054 Myocardial grafts and cellular compositions useful for same
05/18/2004US6737040 Method and antibody for imaging breast cancer
05/18/2004US6737038 Contacting potential inhibitor and tagged inhibitor of beta-amyloid production with macromolecule containing binding site specific for tagged inhibitor, separating bound inhibitor, determining inhibitory concentration
05/18/2004US6737024 Solid supports for analytical measuring processes
05/18/2004US6737022 System including column containing media for separating aqueous stream of mixed polynucleotides into series of length based fractions; container including single sample vials or wells; ejection chamber receiving and discharging fractions
05/18/2004US6736978 Flowing stream past giant magnetoresistive sensor in proximity to cause magnetic properties of stream to produce electrical output signals from sensor, monitoring signals as indicator of analyte concentration, distribution and/or magnetic property
05/18/2004US6736883 Particulate separation system for mercury analysis
05/18/2004US6736777 Biosensor, iontophoretic sampling system, and methods of use thereof
05/18/2004US6736017 High throughput mechanical rapid serial property testing of materials libraries
05/18/2004US6736010 Method and device for counting inclusions in a liquid metal bath with ultrasounds
05/18/2004US6736001 Device for the non-contact storage of components
05/18/2004CA2447359A1 Validated design for microarrays
05/18/2004CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
05/18/2004CA2201283C Platelet blockade assay
05/18/2004CA2127355C Analytical or monitoring apparatus and method
05/14/2004CA2449240A1 Wash process for a sample being analyzed
05/14/2004CA2444754A1 Method, system and reaction vessel for processing a biological sample contained in a liquid
05/14/2004CA2411827A1 Method of immobilizing membrane-associated molecules
05/13/2004WO2004040948A1 Apparatus and method for controlling registration of print steps in a continuous process for the manufacture of electrochemical sensors
05/13/2004WO2004040317A1 Sensor device for determining protein aggregation
05/13/2004WO2004040316A2 Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
05/13/2004WO2004040315A1 Process for producing labeled nucleic acid or protein
05/13/2004WO2004040314A1 A method for assessment of particles
05/13/2004WO2004040313A1 Urothelial cancer tumor marker
05/13/2004WO2004040312A2 Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use
05/13/2004WO2004040311A1 Means and methods for diagnosing a treponema infection
05/13/2004WO2004040310A1 Means and method for diagnosing a treponema infection
05/13/2004WO2004040309A1 Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation
05/13/2004WO2004040308A1 Sugar binding surface
05/13/2004WO2004040307A2 Device and method for analyzing the structure of complex glycostructures and for detecting same
05/13/2004WO2004040306A1 Diagnostic device and kit
05/13/2004WO2004040305A1 Method of immobilizing compound on solid phase support
05/13/2004WO2004040304A2 Digoxin labelled proteins and production and uses thereof
05/13/2004WO2004040302A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1
05/13/2004WO2004040301A1 Method of diagnosing type 2 diabetes
05/13/2004WO2004040300A2 Method of using animal models to predict adverse drug reactions
05/13/2004WO2004040299A2 Method for identifying compounds which inhibit mechanotransduction in neurons
05/13/2004WO2004040298A2 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment
05/13/2004WO2004040297A1 A method of establishing stress relieving procedures for minimizing sulfide stress cracking in cold worked metals
05/13/2004WO2004040290A1 Manufacture of electrochemical sensors by moveable flat screen printing
05/13/2004WO2004040288A1 Analytical tool
05/13/2004WO2004040287A1 Method of manufacture of electrochemical sensors
05/13/2004WO2004040285A2 Preconditioning of a substrate in a continuous process for manufacture of electrochemical sensors
05/13/2004WO2004040284A1 Method of performing calibration and quality control of a sensor and apparatus for performing said method
05/13/2004WO2004040282A1 Probe for physical properties measurement
05/13/2004WO2004040274A1 A method and a device for making images of the quantum efficiency of the photosynthetic system with the purpose of determining the quality of plant material and a method and a device for measuring, classifying and sorting plant material
05/13/2004WO2004040263A2 Diagnostic test for west nile virus
05/13/2004WO2004040259A2 Screening, quantitation and identification of active ingredients in natural products
05/13/2004WO2004040257A2 NOx MONITOR USING DIFFERENTIAL MOBILITY SPECTROMETRY
05/13/2004WO2004040253A2 Secretion-testing article
05/13/2004WO2004040252A2 Molecules and methods using same for measuring non-transferrin bound iron
05/13/2004WO2004040019A1 Method of amplifying nucleic acid
05/13/2004WO2004040010A1 Assay for the screening of compounds acting through erbb-2
05/13/2004WO2004040005A1 Cooling stations for use in a web printing process for the manufacture of electrochemical sensors
05/13/2004WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use
05/13/2004WO2004039990A2 Cells for determining the presence of a molecule that activates signal transduction activity of a cell surface protein
05/13/2004WO2004039982A1 Enzymes dephosphorylating actin depolymerizing factor cofilin and genes thereof
05/13/2004WO2004039976A1 Novel glycosyltransferase, nucleic acid encoding the same and method of detecting cancer tissue using the nculeic acid
05/13/2004WO2004039975A1 Nucleic acids isolated from neuroblastoma at stage 4s
05/13/2004WO2004039967A1 Immortalized natural killer cell line
05/13/2004WO2004039963A2 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
05/13/2004WO2004039962A2 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
05/13/2004WO2004039955A2 Modulators of angiogenesis and tumorigenesis
05/13/2004WO2004039953A2 Array oligomer synthesis and use.
05/13/2004WO2004039948A2 Actriib fusion polypeptides and uses therefor
05/13/2004WO2004039941A2 METHODS OF SCREENING FOR TRPM4b MODULATORS
05/13/2004WO2004039898A1 Ink composition and method for use thereof in the manufacturing of electrochemical sensors
05/13/2004WO2004039897A2 Process for making an electrochemical sensor
05/13/2004WO2004039894A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
05/13/2004WO2004039844A1 Prostate cancer tumor marker
05/13/2004WO2004039843A1 Immunoglobulin g binding pocket
05/13/2004WO2004039842A2 Humanized tissue factor antibodies
05/13/2004WO2004039841A2 Trimeric binding proteins for trimeric cytokines
05/13/2004WO2004039829A2 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
05/13/2004WO2004039765A1 Use of urea variants as affinity ligands
05/13/2004WO2004039600A2 Enzyme print humidification in a continuous process for manufacture of electrochemical sensors
05/13/2004WO2004039489A2 Computer programs,workstations, systems and methods for microfluidic substrates in cell
05/13/2004WO2004039487A1 Multicomponent protein microarrays
05/13/2004WO2004039412A2 Compositions for cancer treatment
05/13/2004WO2004039405A1 Use of sglt homolog